In patients with diabetes and obesity, for example, the likelihood of disease progression increased from 0.1% with low IL-10 and IL-12 (p70) levels to >80% with levels of these cytokines exceeding the 90% sensitivity thresholds. This evidence concerns the gene IL10 and obesity due to melanocortin 4 receptor deficiency.